Abstract
Hypoxia can represent a challenging condition for survival at different biological scales, from cells to organisms. The efficiency of the response to decreased oxygen availability is importantly related to the Hypoxia-Inducible Factors (HIFs) that regulate the transcription of hundreds of genes whose proteins are responsible for changes in metabolism, cell cycle, vascularisation. All these downstream responses are aimed, on one side, to optimise the consumption of oxygen and, on the other side, to change the microenvironment in order to potentially create the conditions to favor oxygen delivery. In this chapter we firstly develop a mathematical model that focuses on the oxygen-dependent regulation of HIFs, on the basis of available biological experiments, we secondly use the model to mathematically investigate the role of HIFs and hypoxia on inflammation and we finally discuss the biological background of the main responses regulated by HIFs and the mathematical models that focused explicitly on HIF action.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aik, W.S., Chowdhury, R., Clifton, I.J., Hopkinson, R.J., Leissing, T., McDonough, M.A., Nowak, R., Schofield, C.J., Walport, L.J.: Introduction to structural studies on 2-oxoglutarate-dependent oxygenases and related enzymes. In: 2-Oxoglutarate-Dependent Oxygenases, pp. 59–94. Royal Society of Chemistry Cambridge, Cambridge (2015)
Appelhoff, R.J., Tian, Y.-M., Raval, R.R., Turley, H., Harris, A.L., Pugh, C.W., Ratcliffe, P.J., Gleadle, J.M.: Differential function of the prolyl hydroxylases phd1, phd2, and phd3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279(37), 38458–38465 (2004)
Arocena, M., Landeira, M., Di Paolo, A., Silva, A., Sotelo-Silveira, J., Fernández, A., Alonso, J.: Using a variant of coverslip hypoxia to visualize tumor cell alterations at increasing distances from an oxygen source. J. Cell. Physiol. 234(10), 16671–16678 (2019)
Bagnall, J., Leedale, J., Taylor, S.E., Spiller, D.G., White, M.R.H., Sharkey, K.J., Bearon, R.N., Sée, V.: Tight control of hypoxia-inducible factor-\(\alpha \) transient dynamics is essential for cell survival in hypoxia. J. Biol. Chem. 289(9), 5549–5564 (2014)
Bartsch, P., Gibbs, J.S.R.: Effect of altitude on the heart and the lungs. Circulation 116(19), 2191–2202 (2007)
Beall, C.M., Cavalleri, G.L., Deng, L., Elston, R.C., Gao, Y., Knight, J., Li, C., Li, J.C., Liang, Y., McCormack, M., et al.: Natural selection on epas1 (hif2\(\alpha \)) associated with low hemoglobin concentration in tibetan highlanders. Proc. Nat. Acad. Sci. USA 107(25), 11459–11464 (2010)
Bedessem, B., Stéphanou, A.: A mathematical model of hif-1\(\alpha \)-mediated response to hypoxia on the g1/s transition. J. Math. Biosci. 248, 31–39 (2014)
Berra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., Pouysségur, J.: Hif prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of hif-1\(\alpha \) in normoxia. EMBO J. 22(16), 4082–4090 (2003)
Bertout, J.A., Majmundar, A.J., Gordan, J.D., Lam, J.C., Ditsworth, D., Keith, B., Brown, E.J., Nathanson, K.L., Simon, M.C.: Hif2\(\alpha \) inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc. Nat. Acad. Sci. USA 106(34), 14391–14396 (2009)
Bocharov, G., Jäger, W., Knoch, J., Neuss-Radu, M., Thiel, M.: A mathematical model of hif-1 regulated cellular energy metabolism. Vietnam J. Math. 49(1), 119–141 (2021)
Brand, A., Singer, K., Koehl, G.E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al.: Ldha-associated lactic acid production blunts tumor immunosurveillance by t and nk cells. Cell Metab. 24(5), 657–671 (2016)
Butcher, D.T., Alliston, T., Weaver, V.M.: A tense situation: forcing tumour progression. Nature Rev. Cancer 9(2), 108–122 (2009)
Chen, E.P., Song, R.S., Chen, X.: Mathematical model of hypoxia and tumor signaling interplay reveals the importance of hypoxia and cell-to-cell variability in tumor growth inhibition. BMC Bioinf. 20(1), 1–15 (2019)
Cogo, A.: The lung at high altitude. Multidisc. Resp. Med. 6(1), 1–2 (2011)
Corbet, C., Feron, O.: Tumour acidosis: From the passenger to the driver’s seat. Nature Rev. Cancer 17(10), 577–593 (2017)
Coulibaly, A., Bettendorf, A., Kostina, E., Figueiredo, A.S., Velasquez Giraldo, S.Y., Bock, H.-G., Thiel, M., Lindner, H.A., Barbarossa, M.V.: Interleukin-15 signaling in hif-1\(\alpha \) regulation in natural killer cells, insights through mathematical models. Front. Immunol. 10(1), 2401 (2019)
Druker, J., Wilson, J.W., Child, F., Shakir, D., Fasanya, T., Rocha, S.: Role of hypoxia in the control of the cell cycle. Int. J. Molec. Sci. 22(9), 4874 (2021)
Ehrismann, D., Flashman, E., Genn, D.N., Mathioudakis, N., Hewitson, K.S., Ratcliffe, P.J., Schofield, C.J.: Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. Biochem. J. 401(1), 227–234 (2007)
Eltzschig, H.K., Carmeliet, P.: Hypoxia and inflammation. New Eng. J. Med. 364(7), 656–665 (2011)
Ferrante, P., Preziosi, L., Scianna, M.: Modelling hypoxia-related inflammation scenarios in tumors. Math. Biosci. 355, 108952 (2023)
Filatova, A., Seidel, S., Böğürcü, N., Gräf, S., Garvalov, B.K., Acker, T.: Acidosis acts through hsp90 in a phd/vhl-independent manner to promote hif function and stem cell maintenance in glioma acidosis promotes hif and glioma stem cells. Cancer Res. 76(19), 5845–5856 (2016)
Gilkes, D.M., Semenza, G.L., Wirtz, D.: Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nature Rev. Cancer 14(6), 430–439 (2014)
Grivennikov, S.I., Greten, F.R., Karin, M.: Immunity, inflammation, and cancer. Cell 140(6), 883–899 (2010)
Hashemzadeh, S., Shahmorad, S., Rafii-Tabar, H., Omidi, Y.: Computational modeling to determine key regulators of hypoxia effects on the lactate production in the glycolysis pathway. Sci. Rep. 10(1), 1–8 (2020)
Hikage, F., Atkins, S., Kahana, A., Smith, T.J., Chun, T.-H.: Hif2\(\alpha \)–lox pathway promotes fibrotic tissue remodeling in thyroid-associated orbitopathy. Endocrinology 160(1), 20–35 (2019)
Holmquist-Mengelbier, L., Fredlund, E., Löfstedt, T., Noguera, R., Navarro, S., Nilsson, H., Pietras, A., Vallon-Christersson, J., Borg, Å, Gradin, K., Poellinger, L., Pahlman, S.: Recruitment of hif-1\(\alpha \) and hif-2\(\alpha \) to common target genes is differentially regulated in neuroblastoma: Hif-2\(\alpha \) promotes an aggressive phenotype. Cancer Cell 10(5), 413–423 (2006)
Honda, T., Hirakawa, Y., Mizukami, K., Yoshihara, T., Tanaka, T., Tobita, S., Nangaku, M.: A distinctive distribution of hypoxia-inducible factor-1\(\alpha \) in cultured renal tubular cells with hypoperfusion simulated by coverslip placement. Physiol. Rep. 9(1), e14689 (2021)
Ji, F., Wang, Y., Qiu, L., Li, S., Zhu, J., Liang, Z., Wan, Y., Di, W.: Hypoxia inducible factor 1\(\alpha \)-mediated lox expression correlates with migration and invasion in epithelial ovarian cancer. Int. J. Oncol. 42(5), 1578–1588 (2013)
Jiang, B.-H., Rue, E., Wang, G.L., Roe, R., Semenza, G.L.: Dimerization, dna binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271(30), 17771–17778 (1996)
Jiang, B.-H., Semenza, G.L., Bauer, C., Marti, H.H.: Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of o2 tension. Am. J. Physiol. Cell Physiol. 271(4):C1172–C1180 (1996)
Kaelin, W.G., Ratcliffe, P.J.: Oxygen sensing by metazoans: the central role of the hif hydroxylase pathway. Molec. Cell 30(4), 393–402 (2008)
Kass, L., Erler, J.T., Dembo, M., Weaver, V.M.: Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int. J. Biochem. Cell Biol. 39(11), 1987–1994 (2007)
Kazyken, D., Lentz, S.I., Fingar, D.C.: Alkaline intracellular ph (phi) activates ampk–mtorc2 signaling to promote cell survival during growth factor limitation. J. Biol. Chem. 297(4) (2021)
Kim, J.-W., Tchernyshyov, I., Semenza G.L., Dang, C.V.: Hif-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3(3), 177–185 (2006)
Koh, M.Y., Powis, G.: Passing the baton: the hif switch. Trends Biochem. Sci. 37(9) 364–372 (2012)
Koivunen, P., Hirsila, M., Kari, I.K., Myllyharju, J.: The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor prolyl 4-hydroxylases. J. Biol. Chem. 281(39), 28712–28720 (2006)
Korbecki, J., Simińska, D., Gassowska-Dobrowolska, M., Listos, J., Gutowska, I., Chlubek, D., Baranowska-Bosiacka, I.: Chronic and cycling hypoxia: drivers of cancer chronic inflammation through hif-1 and nf-\(\kappa \)b activation: A review of the molecular mechanisms. Int. J. Molec. Sci. 22(19), 10701 (2021)
Lanikova, L., Reading, N.S., Hu, H., Tashi, T., Burjanivova, T., Shestakova, A., Siwakoti, B., Thakur, B.K., Pun, C.B., Sapkota, A., et al.: Evolutionary selected tibetan variants of hif pathway and risk of lung cancer. Oncotarget 8(7), 11739 (2017)
Leedale, J., Herrmann, A., Bagnall, J., Fercher, A., Papkovsky, D., Sée, V., Bearon, R.N.: Modeling the dynamics of hypoxia inducible factor-1\(\alpha \) (hif-1\(\alpha \)) within single cells and 3d cell culture systems. Math. Biosci. 258, 33–43 (2014)
Liberti, M.V., Locasale, J.W.: The warburg effect: How does it benefit cancer cells? Trends Biochem. Sci. 41(3), 211–218 (2016)
Lin, Q., Yun, Z.: The hypoxia-inducible factor pathway in adipocytes: the role of hif-2 in adipose inflammation and hypertrophic cardiomyopathy. Front. Endocr. 6, 39 (2015)
Lorenzo, F.R., Huff, C., Myllymäki, M., Olenchock, B., Swierczek, S., Tashi, T., Gordeuk, V., Wuren, T., Ri-Li, G., Khan, T.M. McClain, D.A., Koul, P.A., Guchhait, P., Salama, M.E., Xing, J., Semenza, G.L., Liberzon, E., Wilson, A., Simonson, T.S., Jorde, L.B., Kaelin, W.G., Koivunen, P., Prchal, J.T.: A genetic mechanism for tibetan high-altitude adaptation. Nature Genet. 46(9), 951–956 (2014)
Luks, A.M., Swenson, E.R., Bärtsch, P.: Acute high-altitude sickness. Eur. Resp. Rev. 26(143) (2017)
Maheshwari, R., Weis, E.: Thyroid associated orbitopathy. Indian J. Opht. 60(2), 87 (2012)
McKeown, S.R.: Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Brit. J. Radiol. 87(1035), 20130676 (2014)
Metzen, E., Berchner-Pfannschmidt, U., Stengel, P., Marxsen, J., Stolze, I., Klinger, M., Huang, W.Q., Wotzlaw, C., Hellwig-Burgel, T., Jelkmann, W., Acker, H., Fandreyothers, J.: Intracellular localisation of human hif-1\(\alpha \) hydroxylases: implications for oxygen sensing. J. Cell Sci. 116(7), 1319–1326 (2003)
Miller, A.E., Hu, P., Barker, T.H.: Feeling things out: bidirectional signaling of the cell–ecm interface, implications in the mechanobiology of cell spreading, migration, proliferation, and differentiation. Adv. Healthcare Mat. 9(8), 1901445 (2020)
Mu, X., Shi, W., Xu, Y., Xu, C., Zhao, T., Geng, B., Yang, J., Pan, J., Hu, S., Zhang, C., Zhang, J., Wang, C., Shen, J., Che, Y., Liu, Z., Lv, Z., Wen, H., You, Q.: Tumor-derived lactate induces m2 macrophage polarization via the activation of the erk/stat3 signaling pathway in breast cancer. Cell Cycle 17(4), 428–438 (2018)
Nguyen, L.K., Cavadas, M.A.S., Scholz, C.C., Fitzpatrick, S.F., Bruning, U., Cummins, E.P., Tambuwala, M.M., Manresa, M.C., Kholodenko, B.N., Taylor, C.T., Cheong, A.: A dynamic model of the hypoxia-inducible factor 1\(\alpha \) (hif-1\(\alpha \)) network. J. Cell Sci. 126(6), 1454–1463 (2013)
Nishi, H., Sasaki, T., Nagamitsu, Y., Terauchi, F., Nagai, T., Nagao, T., Isaka, K.: Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells. Oncol. Rep. 35(2), 992–998 (2016)
Papale, M., Buccarelli, M., Mollinari, C., Russo, M.A., Pallini, R., Ricci-Vitiani, L., Tafani, M.: Hypoxia, inflammation and necrosis as determinants of glioblastoma cancer stem cells progression. Int. J. Molec. Sci. 21(8), 2660 (2020)
Paradise, R.K., Lauffenburger, D.A., Van Vliet, K.J.: Acidic extracellular ph promotes activation of integrin \(\alpha \)v\(\beta \)3. PLoS One 6(1), e15746 (2011)
Pektas, S., Knapp, M.J.: Substrate preference of the hif-prolyl hydroxylase-2 (phd2) and substrate-induced conformational change. J. Inorg. Biochem. 126, 55–60 (2013)
Piasentin, N., Milotti, E., Chignola, R.: The control of acidity in tumor cells: A biophysical model. Sci. Rep. 10(1), 1–14 (2020)
Pichiule, P., Chavez, J.C., Schmidt, A.M., Vannucci, S.J.: Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia. J. Biol. Chem. 282(50), 36330–36340 (2007)
Pressley, M., Gallaher, J.A., Brown, J.S., Tomaszewski, M.R., Borad, P., Damaghi, M., Gillies, R.J., Whelan, C.J.: Cycling hypoxia selects for constitutive hif stabilization. Sci. Rep. 11(1), 1–14 (2021)
Qutub, A.A., Popel, A.S.: Three autocrine feedback loops determine hif1\(\alpha \) expression in chronic hypoxia. J. Biochim. Biophys. Acta Molec. Cell Res. 1773(10), 1511–1525 (2007)
Robey, I.F., Lien, A.D., Welsh, S.J., Baggett, B.K., Gillies, R.J.: Hypoxia-inducible factor-1\(\alpha \) and the glycolytic phenotype in tumors. Neoplasia 7(4), 324–330 (2005)
Robinson, P.J., Hack, C.E.: Mathematical model of hif-1\(\alpha \) pathway, oxygen transport and hypoxia. Internal Report U.S. Army, AFRL-RH-WP-TR-2017-0080 (2017)
Ronen, R., Zhou, D., Bafna, V., Haddad, G.G.: The genetic basis of chronic mountain sickness. Physiology 29(6), 403–412 (2014)
Salmond, R.J.: mtor regulation of glycolytic metabolism in t cells. Front. Cell Dev. Biol. 6, 122 (2018)
Schmierer, B., Novák, B., Schofield, C.J.: Hypoxia-dependent sequestration of an oxygen sensor by a widespread structural motif can shape the hypoxic response - a predictive kinetic model. BMC Syst. Biol. 4(1), 139 (2010)
Semenza, G.L.: Hydroxylation of hif-1: oxygen sensing at the molecular level. Physiology 19(4), 176–182 (2004)
Semenza, G.L., Jiang, B.-H., Leung, S.W., Passantino, R., Concordet, J.-P., Maire, P., Giallongo, A.: Hypoxia response elements in the aldolase a, enolase 1, and lactate dehydrogenase a gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271(51), 32529–32537 (1996)
Stiehl, D.P., Bordoli, M.R., Abreu-Rodriguez, I., Wollenick, K., Schraml, P., Gradin, K., Poellinger, L., Kristiansen, G., Wenger, R.H.: Non-canonical hif-2\(\alpha \) function drives autonomous breast cancer cell growth via an areg–egfr/erbb4 autocrine loop. Oncogene 31(18), 2283–2297 (2012)
Stiehl, D.P., Wirthner, R., Koditz, J., Spielmann, P., Camenisch, G., Wenger, R.H.: Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels: evidence for an autoregulatory oxygen-sensing system. J. Biol. Chem. 281(33), 23482–23491 (2006)
Tafani, M., Schito, L., Pellegrini, L., Villanova, L., Marfe, G., Anwar, T., Rosa, R., Indelicato, M., Fini, M., Pucci, B., Russo, M.A.: Hypoxia-increased rage and p2x7r expression regulates tumor cell invasion through phosphorylation of erk1/2 and akt and nuclear translocation of nf-\(\kappa \)b. Carcinogenesis 32(8), 1167–1175 (2011)
Taneja, S., Vetter S.W., Leclerc, E.: Hypoxia and the receptor for advanced glycation end products (rage) signaling in cancer. Int. J. Mol. Sci. 22(15), 8153 (2021)
Tay, S., Hughey, J.J., Lee, T.K., Lipniacki, T., Quake, S.R., Covert, M.W.: Single-cell nf-\(\kappa \)b dynamics reveal digital activation and analogue information processing. Nature 466(7303), 267–271 (2010)
Trayhurn, P.: Hypoxia and adipose tissue function and dysfunction in obesity. Physiol. Rev. 93(1), 1–21 (2013)
Tuckerman, J.R., Zhao, Y., Hewitson, K.S., Tian, Y.-M., Pugh, C.W., Ratcliffe, P.J., Mole, D.R.: Determination and comparison of specific activity of the hif-prolyl hydroxylases. FEBS Lett. 576(1–2), 145–150 (2004)
Vaupel, P.: Tumor microenvironmental physiology and its implications for radiation oncology. In: Seminars in Radiation Oncology, vol. 14, pp. 198–206. Elsevier, Amsterdam (2004)
Villafuerte, F.C., Corante, N.: Chronic mountain sickness: clinical aspects, etiology, management, and treatment. High Alt. Med Biol. 17(2), 61–69 (2016)
Warburg, O.: On the origin of cancer cells. Science 123(3191), 309–314 (1956)
Webb, B.A., Chimenti, M., Jacobson, M.P., Barber, D.L.: Dysregulated ph: A perfect storm for cancer progression. Nature Rev. Cancer 11(9), 671–677 (2011)
Xiang, K., Peng, Y., Yang, Z., Zhang, X., Cui, C., Zhang, H., Li, M., Zhang, Y., Wu, T., Chen, H., et al.: Identification of a tibetan-specific mutation in the hypoxic gene egln1 and its contribution to high-altitude adaptation. Molec. Biol. Evol. 30(8), 1889–1898 (2013)
Xiao, Q., Ge, G.: Lysyl oxidase, extracellular matrix remodeling and cancer metastasis. Cancer Microenv. 5(3), 261–273 (2012)
Xu, L., Fukumura, D., Jain, R.K.: Acidic extracellular ph induces vascular endothelial growth factor (vegf) in human glioblastoma cells via erk1/2 mapk signaling pathway: Mechanism of low ph-induced vegf. J. Biol. Chem. 277(13), 11368–11374 (2002)
Yu, Y., Wang, G., Simha, R., Peng, W., Turano, F., Zeng, C.: Pathway switching explains the sharp response characteristic of hypoxia response network. PLOS Comput. 3(8), e171 (2007)
Zatterale, F., Longo, M., Naderi, J., Raciti, G.A., Desiderio, A., Miele, C., Beguinot, F.: Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front. Physiol. 10, 1607 (2020)
Zhang, N., Fu, Z., Linke, S., Chicher, J., Gorman, J.J., Visk, D., Haddad, G.G., Poellinger, L., Peet, D.J., Powell, F., Johnson, R.S.: The asparaginyl hydroxylase factor inhibiting hif-1\(\alpha \) is an essential regulator of metabolism. Cell Metab. 11(5), 364–378 (2010)
Zhang, B., Ye, H., Yang, A.: Mathematical modelling of interacting mechanisms for hypoxia mediated cell cycle commitment for mesenchymal stromal cells. BMC Syst. Biol. 12, 35 (2018)
Zhao, T., Zhu, Y., Morinibu, A., Kobayashi, M., Shinomiya, K., Itasaka, S., Yoshimura, M., Guo, G., Hiraoka, M., Harada, H.: Hif-1-mediated metabolic reprogramming reduces ros levels and facilitates the metastatic colonization of cancers in lungs. Sci. Rep. 4(1), 1–7 (2014)
Zimna, A., Kurpisz, M.: Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies. BioMed. Res. Int. 2015 (2015)
Acknowledgements
The Authors thank the Medical Student Isabella Ferrante for stimulating and fruitful discussions and for her contribution on the graphics of HIF-related reaction networks.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Ferrante, P., Preziosi, L. (2023). Modelling HIF-PHD Dynamics and Related Downstream Pathways. In: Bretti, G., Natalini, R., Palumbo, P., Preziosi, L. (eds) Mathematical Models and Computer Simulations for Biomedical Applications. MCHBS 2021. SEMA SIMAI Springer Series, vol 33. Springer, Cham. https://doi.org/10.1007/978-3-031-35715-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-031-35715-2_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-35714-5
Online ISBN: 978-3-031-35715-2
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)